Wilson Sonsini Goodrich & Rosati represented Relyance in the transaction. Relyance AI, a leading AI-powered data governance platform that provides complete visibility and control over enterprise-wide...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Verona Pharma on patent matters on the deal. Verona Pharma plc (Nasdaq: VRNA) announced that the U.S. Food and Drug...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Runware in the deal. Runware, a generative AI start-up, announced it has secured $3 million in funding from a16z Speedrun,...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented WuXi AppTec and WuXi HK in the offering. WuXi AppTec (HongKong) Limited (WuXi HK), WuXi AppTec Co., Ltd (WuXi AppTec),...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Maven Clinic in the transaction. Maven Clinic (Maven), the world’s largest virtual clinic for women’s and family health, announced it...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Ahren, OMX Ventures, +ND Capital, and Fine Structures Ventures on the transaction. Constructive Bio, a pioneering synthetic genomics company, announced...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aembit on the transaction. Aembit, a leading non-human identity and access management (IAM) company, has secured $25 million in Series...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Valdera on the transaction. Valdera, an AI-driven sourcing platform for chemicals and raw materials, announced securing $15 million in Series...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Pure Lithium on the transaction. Pure Lithium Corporation, a disruptive Boston-based vertically integrated lithium metal battery technology company, announced the...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Aytu BioPharma on the transaction. Aytu BioPharma, Inc. (the “Company” or “Aytu”) (Nasdaq:AYTU) and Lupin Pharma Canada Ltd (“Lupin”), a...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised 858 Therapeutics on intellectual property matters related to the transaction. 858 Therapeutics announced raising $50 million in a Series B...
You must be a Standard 1 Year member to access this content.
Sidley Austin is advising Ridgeview Partners on the transaction, and Wilson, Sonsini, Goodrich & Rosati is advising PayRange. Ridgeview Partners, a growth-oriented technology private equity firm,...
You must be a Standard 1 Year member to access this content.
